BRIEF published on 10/10/2024 at 18:05, 2 years ago AXA Reveals Share Capital and Voting Rights Data as of September 2024 Euronext Paris Share Capital Voting Rights AXA Threshold Disclosure
BRIEF published on 10/10/2024 at 18:05, 2 years ago AXA : Détails sur le Capital Social en Actions et Droits de Vote Droits De Vote Réglementation Financière Franchissement De Seuil Capital Social AXA
REGULATED PRESS RELEASE published on 10/10/2024 at 18:00, 2 years ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2024 AXA, a public company under French law, discloses information on voting rights and shares making up the share capital in accordance with legal regulations Share Capital Voting Rights AXA Regulations French Law
REGULATED PRESS RELEASE published on 10/10/2024 at 18:00, 2 years ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/09/2024 AXA déclare le nombre total d'actions et de droits de vote composant le capital social selon les règlements en vigueur Autorité Des Marchés Financiers Déclaration Droits De Vote Capital Social AXA
BRIEF published on 10/02/2024 at 18:55, 2 years 1 month ago AXA: Elimination de l'effet dilutif de l'opération Shareplan 2024 Rachat D'actions AXA Augmentation De Capital Effet Dilutif Shareplan 2024
BRIEF published on 10/02/2024 at 18:55, 2 years 1 month ago AXA Implements Share Repurchase to Neutralize Shareplan 2024 Dilution Share Repurchase AXA Shareplan 2024 Dilution Mitigation Employee Share Offering
REGULATED PRESS RELEASE published on 10/02/2024 at 18:50, 2 years 1 month ago AXA: Elimination de l'effet dilutif de l'opération Shareplan 2024 AXA élimine l'effet dilutif de l'opération Shareplan 2024 en rachetant ses propres actions pour un montant maximum de 452 200 000 euros conformément à son programme de rachat d'actions Rachat D'actions AXA Augmentation De Capital Effet Dilutif Shareplan 2024
REGULATED PRESS RELEASE published on 10/02/2024 at 18:50, 2 years 1 month ago AXA: Elimination of the dilutive impact of Shareplan 2024 AXA eliminates dilutive impact of Shareplan 2024 through share repurchase agreement. Price based on average traded prices, up to Euro 452.2 million. Transaction ends by October 30, 2024 Share Repurchase AXA Investment Services Shareplan 2024 Dilutive Impact
BRIEF published on 09/10/2024 at 18:05, 2 years 1 month ago AXA publie le nombre total de droits de vote et d'actions au 31 août 2024 Droits De Vote Franchissement De Seuil Capital Social Actions AXA
BRIEF published on 09/10/2024 at 18:05, 2 years 1 month ago AXA Discloses Voting Rights and Share Capital as of August 31, 2024 Share Capital Voting Rights French Commercial Code AXA Threshold Disclosure
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 08:15, 11 minutes ago EQS-Adhoc: Airbus SE: Airbus commences multi-year share buyback programme, with launch of the first tranche
Published on 11/09/2026 at 08:05, 21 minutes ago Onodrim Industries secures $300 million Series A at $1.3 billion valuation to strengthen Europe's defence and industrial foundations
Published on 11/09/2026 at 08:00, 27 minutes ago Custodian Property Income REIT plc: Further momentum with majority share-based acquisition strategy, purchasing an £11.0m property portfolio from eight syndicated investment vehicles
Published on 11/09/2026 at 07:00, 1 hour 27 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 27 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 27 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 27 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
